Methylgene Inc: (TSE: T.MYG)

$0.10

0.01 (NA)

Volume 33,000

03:44 PM ET

Overview Quote

Get Overview Quote for:

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

|

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

T.MYG Chart by YCharts

Earnings Estimates

No data available for T.MYG

Average Earnings Estimates for T.MYG

EPS Growth for T.MYG

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
AETERNA ZENTARS AEZS 2.10
ANIKA THERAPEUT ANIK 14.40
GENTIUM SPA-ADR GENT 8.87
AASTROM BIOSCI ASTM 0.57
ACHILLION PHARM ACHN 7.77
ADDEX THERA LTD ADDXF 6.94
AFFYMAX INC AFFY 1.33
ALEXION PHARMA ALXN 102.90
ALKERMES INC ALKS 31.69
ALNYLAM PHARMA ALNY 27.44

Sector:Medical>> Industry:MED-BIOMED/GENE

COMPARE TICKER vs. Its Peers

Zacks Commentary

MethylGene Reports Encouraging Clinical And Preclinical Data

Oct 08, 2012

Business is on Track for MethylGene

Aug 07, 2012

MethylGene (MYG-TO, MYLGF-OTC): Initiating with an Outperform

Jun 05, 2012

More T.MYG Zacks Commentary

Quick Links

Services

My Account

Resources

Client Support

Follow Us

Facebook

Twitter

Linkedin

RSS

You Tube

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.

Copyright 2013 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.